|
|
Volumn 25, Issue 1, 2007, Pages 17-19
|
|
HDAC inhibitors overcome first hurdle
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 PHENYLSULFAMOYLCINNAMOHYDROXAMIC ACID;
4 [N (2 HYDROXYETHYL) N [2 (3 INDOLYL)ETHYL]AMINOMETHYL]CINNAMOHYDROXAMIC ACID;
ANTIBIOTIC AGENT;
ANTIEMETIC AGENT;
BACECA;
BEVACIZUMAB;
CARBOPLATIN;
DEPSIPEPTIDE;
DOCETAXEL;
FLUOROURACIL;
HISTONE DEACETYLASE INHIBITOR;
ITF 2357;
LBH 589;
MGCD 0103;
N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE;
PACLITAXEL;
PCI 24781;
ROMIDEPSIN;
SAVICOL;
TAXANE DERIVATIVE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VORINOSTAT;
ACUTE GRANULOCYTIC LEUKEMIA;
ANGIOGENESIS;
APOPTOSIS;
BREAST CANCER;
CARDIOTOXICITY;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL TRANSFORMATION;
CUTANEOUS T CELL LYMPHOMA;
ELECTROCARDIOGRAM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
KIDNEY CANCER;
LEUKEMIA;
LYMPHOMA;
NONHUMAN;
OVARY CANCER;
PERIPHERAL T CELL LYMPHOMA;
PRIORITY JOURNAL;
PROSTATE CANCER;
QT PROLONGATION;
SHORT SURVEY;
SIDE EFFECT;
SOLID TUMOR;
SUDDEN DEATH;
TORSADE DES POINTES;
CLINICAL TRIALS;
DRUG APPROVAL;
HEART DISEASES;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
NEOPLASMS;
RISK ASSESSMENT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33846142183
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0107-17 Document Type: Short Survey |
|
Times cited : (81)
|
|
References (0)
|
